Mood-Altering Medications Do Not Increase Risk for Post-TIPS Hepatic Encephalopathy
November 12th 2018The use of mood-altering medications does not increase odds for hepatic encephalopathy or hepatic encephalopathy-related hospital admissions after TIPS placement, according to the results of a new study.
Read More
Higher Dose of Simvastatin Leads to Increased Toxicity for Patients With Decompensated Cirrhosis
November 11th 2018Data from a phase 2, double-blind, placebo-controlled study, showed a higher dose of simvastatin was associated with greater liver and muscle toxicity compared with a lower dose for patients with decompensated cirrhosis.
Read More